Crossmark

miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition

Crossref DOI link: https://doi.org/10.1038/s41598-018-20258-8

Published Online: 2018-02-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guo, Chunmei

Zhao, Dongting

Zhang, Qiuling

Liu, Shuqing

Sun, Ming-Zhong
License Information

Text and Data Mining valid from 2018-02-05

Version of Record valid from 2018-02-05
More Information

Article History

Received: 1 June 2017

Accepted: 16 January 2018

First Online: 5 February 2018

Competing Interests

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below